Form 4: Addus HomeCare Director Michael Earley Granted Restricted Stock
Insider Transaction Report
Addus HomeCare Corp. Director Michael Earley received a grant of 1,172 restricted shares of common stock, which are set to vest on June 18, 2026.
Summary
- Michael Earley, a Director of Addus HomeCare Corp. (ADUS), acquired 1,172 shares of common stock.
- The transaction date for this acquisition was June 18, 2025.
- These shares were granted as restricted stock to non-employee directors at a price of $0 per share.
- The granted shares will vest in full on June 18, 2026.
- Following this transaction, Michael Earley directly beneficially owns 11,951 shares of Common Stock.
- Additionally, he indirectly beneficially owns 2,695 shares through Bird Asset Management, LP.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates alignment of director's interests with shareholders through equity compensation, which is a common and generally well-regarded practice.
Positives
- The grant of restricted shares to Director Michael Earley aligns his interests with those of the shareholders, as the value of his compensation is tied to the company's stock performance.
- The vesting schedule encourages long-term commitment and performance from the director.
Future Outlook
The 1,172 restricted shares granted to Director Michael Earley are scheduled to vest in full on June 18, 2026, indicating a future milestone for this equity compensation.
Industry Context
This type of restricted stock grant to non-employee directors is a common practice in the healthcare services industry, as well as across publicly traded companies, to attract and retain qualified board members and align their incentives with long-term shareholder value.
Comparison to Industry Standards
- The practice of granting restricted stock units (RSUs) or restricted shares to non-employee directors is a standard compensation mechanism across various industries, including healthcare, to ensure directors have a vested interest in the company's long-term performance.
- While specific grant sizes vary by company size, industry, and director responsibilities, this grant size for a director at Addus HomeCare Corp. appears to be a routine part of their compensation structure, comparable to similar grants observed at companies like Amedisys Inc. (AMED) or LHC Group (LHCG) before their respective acquisitions, which also utilized equity compensation for their board members.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with long-term shareholder value, potentially leading to more shareholder-centric decision-making.
Next Steps
- The 1,172 restricted shares granted to Michael Earley will vest in full on June 18, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/18/2025 | Date of transaction for the acquisition of 1,172 shares of common stock. |
| 06/20/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 06/18/2026 | Date when the 1,172 restricted shares granted to non-employee directors will vest in full. |
Keywords
Addus HomeCare Corp, ADUS, Michael Earley, Director, Restricted Stock, Stock Grant, Insider Transaction, SEC Form 4, Equity Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.